← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2001Last known activity
Jun 13, 2022
Timeline
1960s
- Jun 1, 1965
Florida International University— Founded
Drugs by trial phase (29 distinct, 23 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Studied for
- Afibrinogenemia
- Attention Deficit Disorder with Hyperactivity
- Blood Coagulation Disorders
- Brain Neoplasms
- Central Nervous System Neoplasms
- Depression
- Depressive Disorder
- Ependymoma
- Glioma
- Hemostatic Disorders
- HIV Infections
- Medulloblastoma
- Mucopolysaccharidoses
- Mucopolysaccharidosis VII
- Neoplasm Metastasis
- Neoplasms
- Nervous System Neoplasms
- Osteosarcoma
- Rhabdoid Tumor
- Sarcoma
- Sarcoma, Ewing
- Surgical Wound
Recent trials (46)
- NCT05469386Lead sponsorPhase 4Jun 13, 2022
- NCT05338801Lead sponsorPhase 4Jun 1, 2022
- NCT05338801Overall official - principal investigatorPhase 4Jun 1, 2022
- NCT05205382Overall official - principal investigatorN/AApr 1, 2022
- NCT05205382Lead sponsorN/AApr 1, 2022
- NCT04685421Reponsible party - principal investigatorPhase 1Jan 6, 2021
- NCT04685421Lead sponsorPhase 1Jan 6, 2021
- NCT04685421Overall official - principal investigatorPhase 1Jan 6, 2021
- NCT04183062Lead sponsorPhase 2Oct 4, 2019
- NCT04183062Overall official - principal investigatorPhase 2Oct 4, 2019
- NCT04192032Reponsible party - principal investigatorN/ANov 15, 2018
- NCT04192032Overall official - principal investigatorN/ANov 15, 2018
- NCT04192032Lead sponsorN/ANov 15, 2018
- NCT03511976Lead sponsorPhase 4May 14, 2018
- NCT03589599Lead sponsorN/AMar 21, 2017
Details
- Founded
- Miami, FL, US Jun 1, 1965
- Last known activity
- Jun 13, 2022